Correlation Between Effector Therapeutics and DatChat
Can any of the company-specific risk be diversified away by investing in both Effector Therapeutics and DatChat at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Effector Therapeutics and DatChat into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Effector Therapeutics and DatChat, you can compare the effects of market volatilities on Effector Therapeutics and DatChat and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Effector Therapeutics with a short position of DatChat. Check out your portfolio center. Please also check ongoing floating volatility patterns of Effector Therapeutics and DatChat.
Diversification Opportunities for Effector Therapeutics and DatChat
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Effector and DatChat is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Effector Therapeutics and DatChat in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DatChat and Effector Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Effector Therapeutics are associated (or correlated) with DatChat. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DatChat has no effect on the direction of Effector Therapeutics i.e., Effector Therapeutics and DatChat go up and down completely randomly.
Pair Corralation between Effector Therapeutics and DatChat
If you would invest (100.00) in Effector Therapeutics on May 17, 2025 and sell it today you would earn a total of 100.00 from holding Effector Therapeutics or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Effector Therapeutics vs. DatChat
Performance |
Timeline |
Effector Therapeutics |
Risk-Adjusted Performance
Weakest
Weak | Strong |
DatChat |
Effector Therapeutics and DatChat Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Effector Therapeutics and DatChat
The main advantage of trading using opposite Effector Therapeutics and DatChat positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Effector Therapeutics position performs unexpectedly, DatChat can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DatChat will offset losses from the drop in DatChat's long position.Effector Therapeutics vs. Indaptus Therapeutics | Effector Therapeutics vs. Jasper Therapeutics | Effector Therapeutics vs. RenovoRx | Effector Therapeutics vs. Ensysce Biosciences |
DatChat vs. Intelligent Protection Management | DatChat vs. Sphere 3D Corp | DatChat vs. Society Pass | DatChat vs. Context Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |